Picture of Laboratory of America Holdings logo

LH WI — Laboratory of America Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapSuper Stock

Brief: Labcorp Says Non-Human Primate Supply Issue To Negatively Impact Drug Development Revenue Between $80 Mln-$100 Mln Early In The Year - Conf. Call

Feb 16 (Reuters) - Laboratory Corporation of America
Holdings  LH.N :
    * LABCORP - NON-HUMAN PRIMATE SUPPLY ISSUE TO NEGATIVELY
IMPACT
DRUG DEVELOPMENT REVENUE BETWEEN $80 MILLION-$100 MILLION EARLY
IN THE YEAR - CONF. CALL

Further company coverage:  LH.N 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Laboratory of America Holdings

See all news